Clinical Trial Update: NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial (NEO-SPACE) evaluating pembrolizumab with chemoradiation in nasopharyngeal carcinoma has results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: NPC | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-12-24